Pieris Pharmaceuticals Stock (NASDAQ: PIRS) stock price, news, charts, stock research, profile.
You can purchase shares of Pieris Pharmaceuticals (NASDAQ:PIRS) through any online brokerage.
Other companies in Pieris Pharmaceuticals’s space includes: Curis (NASDAQ:CRIS), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT), Geovax Labs (NASDAQ:GOVX) and Palatin Techs (AMEX:PTN).
There is no analysis for Pieris Pharmaceuticals to provide a consensus price target.
The stock price for Pieris Pharmaceuticals (NASDAQ: PIRS) is $16.9 last updated November 8, 2024 at 8:00 AM EST.
There are no upcoming dividends for Pieris Pharmaceuticals.
Pieris Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 26, 2024.
There is no upcoming split for Pieris Pharmaceuticals.
Pieris Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.